For the year ending 2025-12-31, CTS had -$12,039K decrease in cash & cash equivalents over the period. $86,374K in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Net earnings | 65,317 |
| Depreciation and amortization | 34,538 |
| Non-cash inventory charges | 0 |
| Pensions and other post-retirement plan expense | 168 |
| Stock-based compensation | 4,889 |
| Restructuring non-cash charges | 0 |
| Deferred income taxes | -412 |
| Change in fair value of contingent consideration liability | -3,575 |
| (gain) loss on foreign currency hedges, net of cash | 320 |
| Goodwill prior period adjustment | 2,194 |
| Accounts receivable | 7,444 |
| Inventories | -1,378 |
| Operating lease assets | -397 |
| Other assets | 2,657 |
| Accounts payable | 4,183 |
| Accrued payroll and benefits | 3,388 |
| Operating lease liabilities | -545 |
| Accrued expenses and other liabilities | 5,141 |
| Pension and other post-retirement plans | -147 |
| Net cash provided by operating activities | 102,105 |
| Capital expenditures | 15,731 |
| Payments for acquisitions, net of cash acquired | 0 |
| Short-term investments | 2,783 |
| Net cash used in investing activities | -18,514 |
| Payments of long-term debt | 1,138,451 |
| Proceeds from borrowings of long-term debt | 1,103,651 |
| Purchase of treasury stock | 56,178 |
| Dividends paid | 4,750 |
| Taxes paid on behalf of equity award participants | 2,710 |
| Contingent consideration payments | 0 |
| Net cash used in financing activities | -98,438 |
| Effect of exchange rate on cash and cash equivalents | 2,808 |
| Net (decrease) increase in cash and cash equivalents | -12,039 |
| Cash and cash equivalents at beginning of year | 94,334 |
| Cash and cash equivalents at end of year | 82,295 |
CTS CORP (CTS)
CTS CORP (CTS)